Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally.

The global Preclinical Imaging market is projected to grow at a compound annual growth rate (CAGR) of 5.1% between 2024 and 2034. By 2034, the market's revenue is expected to reach USD 8.36 billion, following a steady growth trajectory. In 2024, the market size is estimated to be valued at USD 4.19 billion.

Request Sample Copy: https://wemarketresearch.c...